Zobrazeno 1 - 10 of 59 pro vyhledávání: '"M A J Van De Sande"'
1
Akademický článek
Enhanced immune responses are accompanied by increased MAGEA expression in osteosarcoma metastases
Autor: Hans Gelderblom, Peter A van Veelen, Noel de Miranda, Arnoud H de Ru, Judith V M G Bovée, Dina Ruano, Marieke Ijsselsteijn, Manon van der Ploeg, Siddh van Oost, Debora M Meijer, Jessica P Roelands, I H Briaire-de Bruijn, B E van den Akker, A B Kruisselbrink, P M Wijers-Koster, S W Lam, R T N Tjokrodirijo, M A J van de Sande, M L Kuijjer
Publikováno v: BMJ Oncology, Vol 3, Iss 1 (2024)
Objective Osteosarcoma is the most common primary bone sarcoma. About 50% of patients develop metastatic disease and their 5-year survival lingers at around 20%–30%. T cell checkpoint blockade immunotherapies have revolutionised cancer treatment in
Externí odkaz: https://doaj.org/article/f7ac0bc0200f4326baebbac92a871b2d
Zobrazit plný text záznamu
2
Akademický článek
Economic burden and health-related quality of life in tenosynovial giant-cell tumour patients in Europe: an observational disease registry
Autor: J. Lopez-Bastida, I. Aranda-Reneo, B. Rodríguez-Sánchez, L. M. Peña-Longobardo, X. Ye, P. Laeis, E. M. Fronk, E. Palmerini, A. Leithner, M. A. J. Van de Sande
Publikováno v: Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-11 (2021)
Abstract Background Tenosynovial Giant-Cell Tumour (TGCT) is a benign clonal neoplastic proliferation arising from the synovium, causing a variety of symptoms and often requiring repetitive surgery. This study aims to define the economic burden—fro
Externí odkaz: https://doaj.org/article/9f550d1992e343f48b0dfd44a6404630
Zobrazit plný text záznamu
3
Akademický článek
Malignant Transformation of Giant Cell Tumor of Bone and the Association with Denosumab Treatment: A Radiology and Pathology Perspective
Autor: K. van Langevelde, A. H. G. Cleven, A. Navas Cañete, L. van der Heijden, M. A. J. van de Sande, H. Gelderblom, J. V. M. G. Bovée
Publikováno v: Sarcoma, Vol 2022 (2022)
Objective. Malignancy in giant cell tumor of bone (mGCTB) is categorized as primary (concomitantly with conventional GCTB) or secondary (after radiotherapy or other treatment). Denosumab therapy has been suggested to play a role in the etiology of se
Externí odkaz: https://doaj.org/article/ccf5de1f03b846b087fd0d79e1bcc5ec
Zobrazit plný text záznamu
4
Akademický článek
Easy-to-use clinical tool for survival estimation in Ewing sarcoma at diagnosis and after surgery
Autor: S. E. Bosma, C. Lancia, A. J. Rueten-Budde, A. Ranft, H. Gelderblom, M. Fiocco, M. A. J. van de Sande, P. D. S. Dijkstra, U. Dirksen
Publikováno v: Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Abstract Accurate survival estimations in Ewing sarcoma are necessary to develop risk- and response adaptive treatment strategies allowing for early decision-making. We aim to develop an easy-to-use survival estimation tool from diagnosis and surgery
Externí odkaz: https://doaj.org/article/7cee7bb701f2453fb5bc3c06609dd1d6
Zobrazit plný text záznamu
5
Cardiotoxicity in Ewing- and osteosarcoma: a 40 year experience from a tertiary sarcoma center
Autor: J C Heemelaar, A A M Al Jaff, E A S Polomski, R E Evenhuis, M A J Van De Sande, A J Gelderblom, F M Speetjens, B J A Mertens, J W Jukema, M L Antoni
Publikováno v: European Heart Journal. 43
Background While malignant bone sarcoma is rare in the general population, it is the second most common malignancy among children and young adults. (Neo)adjuvant systemic treatment carries a significant risk of cardiotoxicity (CTx) in the form of lat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3b46bb589a23c948748048dd207f4fd2
https://doi.org/10.1093/eurheartj/ehac544.2580
Zobrazit plný text záznamu
6
Surgical Outcome and Oncological Survival of Osteofibrous Dysplasia-Like and Classic Adamantinomas
Autor: John H. Healey, J. Hardes, Robin Pollock, Anja J. Rueten-Budde, Jay S. Wunder, M. A. J. van de Sande, Andreas Leithner, Gerard R. Schaap, V. Kostiuk, Tom Cosker, P. Picci, P. D. S. Dijkstra, Mikel San-Julian, Minna Laitinen, Paul C Jutte, Pancras C.W. Hogendoorn, Daniel Baumhoer, Hans Roland Dürr, Per-Ulf Tunn, David Biau, Frank Traub, Xiaohui Niu, E.M. Schutgens, A. Gomez-Brouchet, R. Capanna, Gwen Sys, Judith V.M.G. Bovée, Philipp T. Funovics
Publikováno v: Journal of Bone and Joint Surgery-American Volume, 102(19), 1703-1713. LIPPINCOTT WILLIAMS & WILKINS
Journal of Bone and Joint Surgery, 102(19), 1703-1713. LIPPINCOTT WILLIAMS & WILKINS
Journal of bone and joint surgery. American volume, 102(19), 1703-1713. Journal of Bone and Joint Surgery Inc.
BACKGROUND: Osteofibrous dysplasia-like adamantinoma (OFD-AD) and classic adamantinoma (AD) are rare, neoplastic diseases with only limited data supporting current treatment protocols. We believe that our retrospective multicenter cohort study is the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac10d512f931a6c846d7b333c0a5ce8a
https://doi.org/10.2106/jbjs.19.01056
Zobrazit plný text záznamu
9
Extent of Extraskeletal Manifestations of Fibrous Dysplasia/McCune-Albright Syndrome in Patients with Mazabraud's Syndrome
Autor: Roland Chapurlat, D. Gensburger, P. D. S. Dijkstra, Natasha M. Appelman-Dijkstra, M. A. J. van de Sande, Marlous Hagelstein-Rotman, Alison M. Boyce, B.C.J. Majoor, N B J Dur
Publikováno v: Calcified Tissue International. SPRINGER
Calcified Tissue International
Mazabraud's syndrome (MZB) is a rare condition in which fibrous dysplasia of bone/the McCune-Albright syndrome (FD/MAS) co-exists with intramuscular myxomas. Both FD and the myxomas harbor the GNAS-mutation. Recent studies have shown that extraskelet
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01e35b8aa0b598964742fb9628fa496f
https://doi.org/10.1007/s00223-021-00918-0
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje